Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer20 Feb ETF FEBW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$982K Hold
27,638
﹤0.01% 2161
2026
Q1
$925K Buy
27,638
+6,356
+30% +$216K ﹤0.01% 2235
2025
Q4
$723K Sell
21,282
-5,033
-19% -$168K ﹤0.01% 2387
2025
Q3
$872K Sell
26,315
-1,556
-6% -$50.6K ﹤0.01% 2155
2025
Q2
$890K Buy
27,871
+555
+2% +$17K ﹤0.01% 2044
2025
Q1
$830K Buy
27,316
+7,131
+35% +$221K ﹤0.01% 2008
2024
Q4
$625K Sell
20,185
-5,948
-23% -$183K ﹤0.01% 2244
2024
Q3
$794K Sell
26,133
-3,619
-12% -$108K ﹤0.01% 2043
2024
Q2
$882K Buy
29,752
+1,324
+5% +$38.5K ﹤0.01% 1861
2024
Q1
$823K Buy
28,428
+19,338
+213% +$549K ﹤0.01% 1859
2023
Q4
$253K Sell
9,090
-210
-2% -$5.64K ﹤0.01% 2721
2023
Q3
$243K Hold
9,300
﹤0.01% 2664
2023
Q2
$246K Hold
9,300
﹤0.01% 2701
2023
Q1
$235K Buy
+9,300
New +$232K ﹤0.01% 2689

Other funds holding FEBW

Cambridge Investment Research Advisors's FEBW Position: Q2 2026 in Review

Cambridge Investment Research Advisors held its AllianzIM U.S. Equity Buffer20 Feb ETF (FEBW) position steady in Q2 2026 at 27,638 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #2161.

Cambridge Investment Research Advisors first reported a position in FEBW in Q1 2023 and has held it in 14 quarters since. 25 funds tracked by Wall St. Rank hold FEBW as of Q2 2026.

  • Cambridge Investment Research Advisors held 27,638 shares of AllianzIM U.S. Equity Buffer20 Feb ETF worth $982K as of Q2 2026.
  • Cambridge Investment Research Advisors left its AllianzIM U.S. Equity Buffer20 Feb ETF share count unchanged in Q2 2026.
  • AllianzIM U.S. Equity Buffer20 Feb ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2161 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer20 Feb ETF in Q1 2023 and has held it in 14 quarters since.
  • 25 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Feb ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.